T-cell prolymphocytic leukaemia in a patient with chronic myeloid leukaemia receiving nilotinib: first documented report - Hanley, B; Nesr, G; Yebra-Fernandez, E; Brown, L; Rabitsch, A; Killeen, N; Claudiani, S; Milojkovic, D; Kanfer, E; Apperley, J; Naresh, KN (JOURNAL OF CLINICAL PATHOLOGY, 2019)